131 related articles for article (PubMed ID: 35016253)
1. Recurrence and Metachronous Disease in Children with Benign Ovarian Tumors: A Systematic Review of the Literature.
Braungart S; Smith CV
Eur J Pediatr Surg; 2022 Feb; 32(1):98-104. PubMed ID: 35016253
[TBL] [Abstract][Full Text] [Related]
2. Ovarian tumors in children: how common are lesion recurrence and metachronous disease? A UK CCLG Surgeons Cancer Group nationwide study.
Braungart S; ; Craigie RJ; Farrelly P; Losty PD
J Pediatr Surg; 2020 Oct; 55(10):2026-2029. PubMed ID: 31837839
[TBL] [Abstract][Full Text] [Related]
3. Metachronous benign ovarian tumors are not uncommon in children.
Taskinen S; Urtane A; Fagerholm R; Lohi J; Taskinen M
J Pediatr Surg; 2014 Apr; 49(4):543-5. PubMed ID: 24726109
[TBL] [Abstract][Full Text] [Related]
4. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract][Full Text] [Related]
5. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
6. Ovarian-sparing surgery for ovarian tumors in children: A systematic review and meta-analysis.
Pio L; Abu-Zaid A; Zaghloul T; Halepota HF; Davidoff AM; Losty PD; Abdelhafeez HH
Eur J Surg Oncol; 2023 Oct; 49(10):106923. PubMed ID: 37211469
[TBL] [Abstract][Full Text] [Related]
7. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
[TBL] [Abstract][Full Text] [Related]
8. Long-term surgical outcomes in pediatric ovarian neoplasms: 20-year single-center experience.
Toker Kurtmen B; Dokumcu Z; Divarci E; Ergun O; Ozok G; Celik A
Pediatr Surg Int; 2022 Dec; 38(12):2035-2044. PubMed ID: 36169670
[TBL] [Abstract][Full Text] [Related]
9. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
10. Improving the clinical management of women with borderline tumours: a recurrence risk scoring system from a French multicentre study.
Ouldamer L; Bendifallah S; Nikpayam M; Body G; Fritel X; Uzan C; Morice P; Daraï E; Ballester M
BJOG; 2017 May; 124(6):937-944. PubMed ID: 28122418
[TBL] [Abstract][Full Text] [Related]
11. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
[TBL] [Abstract][Full Text] [Related]
12. Management of pediatric benign ovarian tumors in England and Egypt: A comparative study.
Elgendy A; Lakshminarayanan B; Elrouby A; Mostafa M; Salem MA; Turner K; Khairi A; Squire R; K Shehata SM; Shehata S; Powis M
Afr J Paediatr Surg; 2020; 17(1-2):33-38. PubMed ID: 33106451
[TBL] [Abstract][Full Text] [Related]
13. New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components.
Timor-Tritsch IE; Foley CE; Brandon C; Yoon E; Ciaffarrano J; Monteagudo A; Mittal K; Boyd L
Ultrasound Obstet Gynecol; 2019 Sep; 54(3):395-402. PubMed ID: 30950132
[TBL] [Abstract][Full Text] [Related]
14. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
15. Borderline Ovarian Tumor in the Pediatric and Adolescent Population: A Case Series and Literature Review.
Childress KJ; Patil NM; Muscal JA; Dietrich JE; Venkatramani R
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):48-54. PubMed ID: 28899828
[TBL] [Abstract][Full Text] [Related]
16. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
17. Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
May J; Skorupskaite K; Congiu M; Ghaoui N; Walker GA; Fegan S; Martin CW; O'Donnell RL
Int J Gynecol Cancer; 2018 Nov; 28(9):1683-1691. PubMed ID: 30365457
[TBL] [Abstract][Full Text] [Related]
18. Standardizing the surgical management of benign ovarian tumors in children and adolescents: A best practice Delphi consensus statement.
Braungart S; Williams C; Arul SG; Bambang K; Craigie RJ; Cross KM; Dick A; Hammond P; Okoye B; Rogers T; Losty PD; Glaser A; Powis M
Pediatr Blood Cancer; 2022 Apr; 69(4):e29589. PubMed ID: 35118808
[TBL] [Abstract][Full Text] [Related]
19. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.
Akeson M; Zetterqvist BM; Dahllöf K; Jakobsen AM; Brännström M; Horvath G
Int J Gynecol Cancer; 2008; 18(3):453-9. PubMed ID: 18476948
[TBL] [Abstract][Full Text] [Related]
20. Sinonasal inverted papillomas: recurrence, and synchronous and metachronous malignancy.
Mirza S; Bradley PJ; Acharya A; Stacey M; Jones NS
J Laryngol Otol; 2007 Sep; 121(9):857-64. PubMed ID: 17319993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
